CHLORHEXIDINE GLUCONATE 4% and ERYTHEMA

Overview

ERYTHEMA is the #11 most commonly reported adverse reaction for CHLORHEXIDINE GLUCONATE 4%, manufactured by Xttrium Laboratories, Inc.. There are 2 FDA adverse event reports linking CHLORHEXIDINE GLUCONATE 4% to ERYTHEMA. This represents approximately 1.7% of all 120 adverse event reports for this drug.

Patients taking CHLORHEXIDINE GLUCONATE 4% who experience erythema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ERYTHEMA2 of 120 reports

ERYTHEMA is a less commonly reported adverse event for CHLORHEXIDINE GLUCONATE 4%, but still significant enough to appear in the safety profile.

Other Side Effects of CHLORHEXIDINE GLUCONATE 4%

In addition to erythema, the following adverse reactions have been reported for CHLORHEXIDINE GLUCONATE 4%:

RASH — 5 reports
HYPERSENSITIVITY — 4 reports
ACCIDENTAL EXPOSURE TO PRODUCT — 3 reports
EYE IRRITATION — 3 reports
PAIN — 3 reports
ALOPECIA — 2 reports
APPLICATION SITE PRURITUS — 2 reports
BURKHOLDERIA INFECTION — 2 reports
COMPLICATION OF DEVICE INSERTION — 2 reports
DIARRHOEA — 2 reports

Other Drugs Associated with ERYTHEMA

The following drugs have also been linked to erythema in FDA adverse event reports:

5% LIDOCAINE ACETAMINOPHEN 325MG ACETIC ACID ADAPALENE ADAPALENE AND BENZOYL PEROXIDE AGNUS CASTUS ALUMINUM CHLOROHYDRATE ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY AMPICILLIN SODIUM AND SULBACTAM SODIUM APIS MELLIFERA AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%AVOBENZONE, HOMOSALATE, OCTISALATE AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE AVOBENZONE, OCTISALATE, AND OCTOCRYLENE BACITRACIN BACITRACIN ZINC BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE

Does CHLORHEXIDINE GLUCONATE 4% cause ERYTHEMA?

ERYTHEMA has been reported as an adverse event in 2 FDA reports for CHLORHEXIDINE GLUCONATE 4%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ERYTHEMA with CHLORHEXIDINE GLUCONATE 4%?

ERYTHEMA accounts for approximately 1.7% of all adverse event reports for CHLORHEXIDINE GLUCONATE 4%, making it a notable side effect.

What should I do if I experience ERYTHEMA while taking CHLORHEXIDINE GLUCONATE 4%?

If you experience erythema while taking CHLORHEXIDINE GLUCONATE 4%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.